Literature DB >> 31381940

Perfusion CHO cell culture applied to lower aggregation and increase volumetric productivity for a bispecific recombinant protein.

Natalia Gomez1, Hedieh Barkhordarian2, Jonathan Lull2, Joon Huh3, Pavan GhattyVenkataKrishna3, Xin Zhang4.   

Abstract

Secreted recombinant proteins can aggregate during cell culture. We studied a poorly-behaved bispecific scaffold that increasingly aggregated (up to 62% high molecular weight species, HMW) as a function of culture time in a fed-batch and intensified cell culture processes. We identified that protein aggregates increased with accumulated protein concentration inside the bioreactor. Furthermore, results indicated that a maximum product concentration was reached beyond which no additional soluble protein accumulated in culture even when doubling the integrated viable cell density with the intensified process, suggesting additional secreted protein was precipitating. To overcome this limitation and maintain the cell-specific productivity (qp) in culture, we explored a perfusion process where recombinant protein was continuously removed from the bioreactor to maintain low product concentration and consequently, minimize protein aggregation. We studied different viable cell densities (VCDs) inside the bioreactor (one to five-fold) and found a corresponding two-fold modulation of monomer levels. In all VCD conditions, qp was maintained. On the contrary, the previous intensified process showed an "apparent" 2.5-fold decrease in qp at the end of culture because of the presumed limited protein solubility at higher concentrations. The combination of lower aggregate levels and constant qp resulted in up to four to five-fold increase in recoverable product (i.e., monomer) with the improved perfusion process.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell-specific productivity; High molecular weight species; Intensified process

Mesh:

Substances:

Year:  2019        PMID: 31381940     DOI: 10.1016/j.jbiotec.2019.08.001

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  5 in total

Review 1.  Recombinant antibodies aggregation and overcoming strategies in CHO cells.

Authors:  Tingting Xu; Jihong Zhang; Tianyun Wang; Xiaoyin Wang
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-24       Impact factor: 4.813

2.  Productivity and quality improvement for a symmetric bispecific antibody through the application of intensified perfusion cell culture.

Authors:  Yongjun Qin; Rongmei Ma; Yang Li; Yifeng Li; Gong Chen; Weichang Zhou
Journal:  Antib Ther       Date:  2022-05-03

3.  Engineering death resistance in CHO cells for improved perfusion culture.

Authors:  Michael A MacDonald; Matthias Nöbel; Verónica S Martínez; Kym Baker; Evan Shave; Peter P Gray; Stephen Mahler; Trent Munro; Lars K Nielsen; Esteban Marcellin
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

4.  Model predictive control for steady-state performance in integrated continuous bioprocesses.

Authors:  Magdalena Pappenreiter; Sebastian Döbele; Gerald Striedner; Alois Jungbauer; Bernhard Sissolak
Journal:  Bioprocess Biosyst Eng       Date:  2022-08-02       Impact factor: 3.434

5.  Perfusion reduces bispecific antibody aggregation via mitigating mitochondrial dysfunction-induced glutathione oxidation and ER stress in CHO cells.

Authors:  Pritam Sinharoy; Aaron H Aziz; Natalia I Majewska; Sanjeev Ahuja; Michael W Handlogten
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.